Results 51 to 60 of about 3,867 (204)

Piracetam in Therapy of Vertigo [PDF]

, 2000
Piracetam (Oikamid®) je višestruko primjenljiv lijek čija upotreba traje više od 25 godina. U radu su opisana obilježja piracetama (Oikamid®) kao lijeka i vrtoglavice kao simptoma koji se liječi. Istaknuti su rezultati nekoliko studija o mogućnostima
Tinjić, Ljulijeta, Sinanović, Osman, Smajlović, Dževdet, Tupković, Emir, Ibrahimagić, Omer Ć., Šehanović, Emir, Brkić, Fuad   +6 more
core  

POSSIBILITIES TO USE A FIXED COMBINATION OF PIRACETAM AND CINNARIZINE IN NEUROLOGICAL PRACTICE

Медицинский совет, 2017
The article discusses  the  possibility of using the  complex drug Phezam, containing 400  mg of Piracetam and 25  mg of Cinnarizine in neurological practice.
N. V. Titova
doaj   +1 more source

Almond (Amygdalus communis L.) Peptides Improve Scopolamine‐Induced Learning and Memory Impairment in Mice

Food Safety and Health, Volume 4, Issue 3, Page 641-652, July 2026.
Figure Schematic showing the improvement of almond peptides on learning and memory impairment induced by scopolamine in mice. Almond peptides (APs) could improve the learning and memory in scopolamine‐induced mice by maintaining cholinergic system homeostasis and regulating Nrf2/Keap1 signaling pathway, via activating the Nrf2 transcription factor and ...
Xin Shang, Wenjing Gao, Caiyun Zhao, Bin Li, Jintian Guo, Jingteng Wang, Minwei Zhang, Yinghua Fu   +7 more
wiley   +1 more source

Electron and electrostatic properties of three crystal forms of piracetam

, 2011
International audienceThe electron densities in three crystal forms of piracetam (triclinic form II, monoclinic form III, and triclinic piracetam monohydrate) were derived from high resolution X-ray diffraction experiments carried out at 100 K.
Gillet, Jean-Michel, Sébastien Lebègue, Jelsch, C., Bonhomme, F., François Bonhomme, Chambrier, M.-H., Lebègue, S., Nour Eddine Ghermani, Jean-Michel Gillet, Ghermani, N.E., Christian Jelsch, Marie-Hélène Chambrier, Nouzha Bouhmaida, Bouhmaida, N.   +13 more
core   +1 more source

Enhanced Neuroplasticity by the Metabolic Enhancer Piracetam Associated with Improved Mitochondrial Dynamics and Altered Permeability Transition Pore Function

Neural Plasticity, 2016
The mitochondrial cascade hypothesis of dementia assumes mitochondrial dysfunction leading to reduced energy supply, impaired neuroplasticity, and finally cell death as one major pathomechanism underlying the continuum from brain aging over mild ...
Carola Stockburger, Davide Miano, Thea Pallas, Kristina Friedland, Walter E. Müller   +4 more
doaj   +1 more source

Neuroprotective Effect of Piracetam against Cocaine-Induced Neuro Epigenetic Modification of DNA Methylation in Astrocytes

Brain Sciences, 2020
Cocaine abuse is known to alter mitochondrial biogenesis and induce epigenetic modification linked with neuronal dysfunction. Cocaine-induced epigenetic modification of DNA methylation and the mitochondrial genome may affect mitochondrial DNA (mtDNA) and
Kalaiselvi Sivalingam, Thangavel Samikkannu   +1 more
doaj   +1 more source

Solution‐Processed Nickel Oxide as Efficient Hole Transport Layers in Inverted Perovskite Solar Cells

Advanced Science, Volume 13, Issue 33, 15 June 2026.
This review summarizes recent advances in four mainstream solution‐based techniques for synthesizing NiOx hole‐transport layers for high‐performance perovskite photovoltaic cells, and highlights the key challenges and future prospects for achieving high efficiency, long‐term stability, and low‐cost perovskite photovoltaic technologies toward ...
Zheng Wu, Zeliang Qiu, Yuxin Tao, Yuyang Qiu, Yuwei Duan, Jianxing Xia, Feng Li, Qiang Peng   +7 more
wiley   +1 more source

Piracetam Co-Crystals with OH-Group Functionalized Carboxylic Acids

, 2016
We report the synthesis, crystal structures, and basic physicochemical properties of six co-crystals of piracetam. Co-crystals of piracetam with l-tartaric acid, with citric acid in a 1:1 and 3:2 ratio, with racemic mandelic acid, and with l-mandelic ...
Fritz Blatter (2376541), Martin Viertelhaus (2376547), Rolf Hilfiker (2376544), Markus Neuburger (1233615)   +3 more
core   +1 more source

Synergy of piracetam and aminalon in the cerebroprotective effect of olatropyl.

Medičnì Perspektivi, 2018
Optimization of pharmacotherapy of neurological and psychosomatic diseases led to the creation of com­bined medicines containing two or more components with different mechanisms of action, differently affecting the pathogenesis and clinical ...
V. I. Mamchur, S. N. Dronov
doaj   +1 more source

Movement Disorders Associated with 22q11.2 Microdeletion: A Scoping Review

Movement Disorders Clinical Practice, Volume 13, Issue 6, Page 1399-1417, June 2026.
Abstract Background Movement disorders have recently emerged as important neurologic manifestations of the 22q11.2 microdeletion that affects nearly one in every 2000 live births. Objective We aimed to map the existing evidence regarding the spectrum, diagnosis and treatment, and etiopathogenesis of movement disorders associated with 22q11.2 ...
Nikolai Gil D. Reyes, Daniel G. Di Luca, Connie Marras, Erik Boot, Ryan K.C. Yuen, Anthony E. Lang, Anne S. Bassett   +6 more
wiley   +1 more source